Zhitong Finance App News, Sihuan Biotech (000518.SZ) announced that the company plans to acquire 80% of the shares of Jilin Changyuan Pharmaceutical Co., Ltd. (“Changyuan Pharmaceutical”) in cash at a transaction price of 160 million yuan. After the transaction is completed, Changyuan Pharmaceutical will become the company's holding subsidiary.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.